“…The abbreviations used are: PGE 2 , prostaglandin E 2 ; T1D, type 1 diabetes; T2D, type 2 diabetes; PLA 2 , phospholipase A 2 ; ALOX12, 12-lipoxygenase (12-LO); CCL2, monocyte chemoattractant protein-1; CCL5, C-C motif chemokine 5 precursor; CDC, cinnamyl-3,4-dihydroxy-␣-cyanocinnamate; CD68, cluster of differentiation; CHIL3, chitinase-like3 (YM1); CXCL10, chemokine (C-X-C motif) ligand 10; COX, cyclooxygenase; iNOS, inducible nitric oxide; cPLA 2 , cytosolic phospholipase A 2 ; iPLA 2 , group VIA phospholipase A 2 ; iPLA 2 ␥, group VIA phospholipase A 2 ␥; LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; LPS, lipopolysaccharide; MRC1, mannose receptor 1c type precursor; NF-B1, nuclear factor -light chain enhancer of activated B-cells (NF-B p105, p50 precursor); NOD, nonobese diabetic; NOX4, NADPH oxidase 4; PTGS2, mouse cyclooxygenase 2 (COX2); RT-qPCR, real time quantitative PCR; RELA, Rel-associated protein (NF-B p65); ROS, reactive oxygen species; S-BEL, S-enantiomer of bromoenol lactone; STAT1 and STAT6, signal transducer and activator of transcription 1 and 6, respectively; Arg, arginase.…”